Evidence map›Paper›PMID 32390420›Full record

ArticleAnalytical chemistry2020

Dynamic Aqueous Multiphase Reaction System for One-Pot CRISPR-Cas12a-Based Ultrasensitive and Quantitative Molecular Diagnosis.

Kun Yin, Xiong Ding, Ziyue Li, Hui Zhao, Kumarasen Cooper, Changchun Liu

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
8.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 210 citations in OpenAlex.

  1. Article
  2. Rapid detection ofMicrobiology spectrum · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kun YinDepartment of Biomedical Engineering, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, Connecticut 06030, United States.
Xiong DingDepartment of Biomedical Engineering, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, Connecticut 06030, United States.ORCID 0000-0003-0437-0589
Ziyue LiDepartment of Biomedical Engineering, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, Connecticut 06030, United States.
Hui ZhaoDepartment of Mechanical Engineering, University of Nevada, Las Vegas, Las Vegas, Nevada 89154, United States.ORCID 0000-0001-5138-6394
Kumarasen CooperDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, 3400 Spruce St. Philadelphia, Pennsylvania 19104, United States.
Changchun LiuDepartment of Biomedical Engineering, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, Connecticut 06030, United States.ORCID 0000-0002-4931-986X
UConn Health · USUniversity of Nevada, Las Vegas · USUniversity of Pennsylvania · US

Funding

Asymmetric CRISPR Approach for Nucleic Acid QuantificationR01EB023607 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI Changchun Liu · 2017 to 2026
$2.4M
Point of Care Diagnostics of HPV-Associated Cervical Cancer in HIV Epidemic Areas in ChinaR01CA214072 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LIU, CHANGCHUN · 2017 to 2021
$771k
Smart Cup: A Mobile Molecular Detection Device for Rapid Diagnosis of Hand Foot and Mouth Disease in ChinaR21TW010625 · FIC · UNIVERSITY OF PENNSYLVANIA · PI LIU, CHANGCHUN · 2017 to 2018
$403k
FIC NIH HHS R21 TW010625NCI NIH HHS R01 CA214072NIBIB NIH HHS R01 EB023607
6 · The paper itself

Abstract

Recently, CRISPR-Cas technology has opened a new era of nucleic acid-based molecular diagnostics. However, current CRISPR-Cas-based nucleic acid biosensing has a lack of the quantitative detection ability and typically requires separate manual operations. Herein, we reported a dynamic aqueous multiphase reaction (DAMR) system for simple, sensitive and quantitative one-pot CRISPR-Cas12a based molecular diagnosis by taking advantage of density difference of sucrose concentration. In the DAMR system, recombinase polymerase amplification (RPA) and CRISPR-Cas12a derived fluorescent detection occurred in spatially separated but connected aqueous phases. Our DAMR system was utilized to quantitatively detect human papillomavirus (HPV) 16 and 18 DNAs with sensitivities of 10 and 100 copies within less than 1 h. Multiplex detection of HPV16/18 in clinical human swab samples were successfully achieved in the DAMR system using 3D-printed microfluidic device. Furthermore, we demonstrated that target DNA in real human plasma samples can be directly amplified and detected in the DAMR system without complicated sample pretreatment. As demonstrated, the DAMR system has shown great potential for development of next-generation point-of-care molecular diagnostics.

Indexed as

Molecular Diagnostic TechniquesNucleic Acid Amplification TechniquesReal-Time Polymerase Chain ReactionBacterial ProteinsCRISPR-Associated ProteinsCRISPR-Cas SystemsDNA, ViralEndodeoxyribonucleasesHuman papillomavirus 16Human papillomavirus 18HumansWaterBacterial ProteinsCas12a proteinCRISPR-Associated ProteinsDNA, ViralEndodeoxyribonucleasesWater

Identifiers

PMID32390420
PMCPMC7588651
OpenAlexW3023764677

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.